Much like with the first antibiotics, the answer to the growing problem of infection control lies in understanding efficient natural anti-pathogenic mechanisms, borrowing their efficiency and transposing this efficiency into clinical practice.
In Nature, T-viruses called Bacteriophages fulfill the role of bacterial growth control. They are extremely specialized “predators” that only affect a set spectrum of pathogens.
We envisage the main advantages of Phage Therapy to be:
- lack of side effects – specific effect exclusively against targeted pathogenic spectrum
- effectiveness – visibly rapid effect in-vitro and in-vivo
- overcomes therapy failure due to resistance
- suitable for combination therapy to boost the effect of regular antibiotics and shorten therapy period
- no gene-technical process
These advantages should result in:
- Effective treatment of certain chronic and nosocomial infections (e.g. MRSA) without burdening the patient with side effects